Detalhe da pesquisa
1.
Perforin expression by CD4+ regulatory T cells increases at multiple sclerosis relapse: sex differences.
Int J Mol Sci
; 13(6): 6698-6710, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22837658
2.
Estradiol-dependent perforin expression by human regulatory T-cells.
Eur J Clin Invest
; 41(4): 357-64, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21114488
3.
A Complete In Vitro Toxicological Assessment of the Biological Effects of Cerium Oxide Nanoparticles: From Acute Toxicity to Multi-Dose Subchronic Cytotoxicity Study.
Nanomaterials (Basel)
; 11(6)2021 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34208428
4.
IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a longitudinal 1-year study.
Clin Immunol
; 134(2): 148-57, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19900844
5.
Expansion of regulatory CD8+ T-lymphocytes and fall of activated CD8+ T-lymphocytes after i.v. methyl-prednisolone for multiple sclerosis relapse.
J Neuroimmunol
; 204(1-2): 131-5, 2008 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18835045
6.
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis.
J Neuroimmunol
; 182(1-2): 204-11, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17157927
7.
Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapy.
J Neuroimmunol
; 176(1-2): 153-61, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16698092
8.
Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity.
Immunol Lett
; 96(2): 195-201, 2005 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-15585323
9.
Sex-hormone receptors pattern on regulatory T-cells: clinical implications for multiple sclerosis.
Clin Exp Med
; 12(4): 247-55, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22227825
10.
Clinical response to interferon-beta-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: a 1-year longitudinal study.
J Neuroimmunol
; 212(1-2): 112-20, 2009 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19446889